VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1
+$2.49M
2
+$2.46M
3
+$2.31M
4
OXLC
Oxford Lane Capital
OXLC
+$2.19M
5
TKO icon
TKO Group
TKO
+$2.17M

Top Sells

1
+$1.99M
2
+$1.62M
3
+$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
426
Dyne Therapeutics
DYN
$2.76B
$99.5K 0.03%
7,869
+1,366
NGNE icon
427
Neurogene
NGNE
$279M
$96.7K 0.03%
5,578
+969
SLNO icon
428
Soleno Therapeutics
SLNO
$2.27B
$95.9K 0.03%
1,419
+247
AVBP icon
429
ArriVent BioPharma
AVBP
$902M
$88.9K 0.03%
4,816
+837
NRIX icon
430
Nurix Therapeutics
NRIX
$1.91B
$87.9K 0.03%
9,514
+1,652
AUTL
431
Autolus Therapeutics
AUTL
$386M
$86.3K 0.02%
52,924
+9,188
MREO
432
Mereo BioPharma
MREO
$112M
$84.3K 0.02%
40,930
+7,105
TRDA icon
433
Entrada Therapeutics
TRDA
$424M
$84.1K 0.02%
14,495
+2,516
TECX
434
Tectonic Therapeutic
TECX
$370M
$79.6K 0.02%
5,071
+881
CGEM icon
435
Cullinan Oncology
CGEM
$633M
$75.4K 0.02%
12,714
+2,208
ALT icon
436
Altimmune
ALT
$455M
$60K 0.02%
15,914
+2,763
CAPR icon
437
Capricor Therapeutics
CAPR
$1.31B
$58.9K 0.02%
8,163
+1,417
REPL icon
438
Replimune Group
REPL
$571M
$48.2K 0.01%
11,511
+1,998
MLTX icon
439
MoonLake Immunotherapeutics
MLTX
$1.16B
$18.5K 0.01%
2,585
+449
BKT.RT
440
DELISTED
BlackRock Income Trust Rights exp October 20 2025
BKT.RT
$3.46K ﹤0.01%
+58,703
KKR icon
441
KKR & Co
KKR
$118B
– –
-12,195
L icon
442
Loews
L
$21.5B
– –
-16,253
MET icon
443
MetLife
MET
$51.8B
– –
-18,432
MRSH
444
Marsh
MRSH
$89.4B
– –
-6,319
MPV
445
Barings Participation Investors
MPV
$201M
– –
-28,448
MSI icon
446
Motorola Solutions
MSI
$65.7B
– –
-3,222
NOC icon
447
Northrop Grumman
NOC
$92.7B
– –
-2,929
NU icon
448
Nu Holdings
NU
$81.4B
– –
-115,382
OKTA icon
449
Okta
OKTA
$16.6B
– –
-13,406
PG icon
450
Procter & Gamble
PG
$340B
– –
-8,605
16 17
18
19 20